Detalhe da pesquisa
1.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood
; 129(10): 1389-1393, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049637
2.
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(2): 333-339, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27826061
3.
Experts' considerations on HLA-haploidentical stem cell transplantation.
Eur J Haematol
; 93(3): 187-97, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24660868
4.
Erratum to: Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation [Biol Blood Marrow Transplant 2017;23:333-339].
Biol Blood Marrow Transplant
; 23(6): 1040, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183535
5.
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera.
Ann Hematol
; 94(5): 873-4, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407111
6.
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement.
Ann Hematol
; 94(8): 1423-4, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25900790
7.
Low-dose rituximab in adult patients with primary immune thrombocytopenia.
Eur J Haematol
; 85(4): 329-34, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20546023
8.
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy.
Am J Hematol
; 90(7): E135-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25808917
9.
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy.
Cancer Res
; 80(12): 2575-2585, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107211
10.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Lancet Haematol
; 7(1): e28-e39, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606445
11.
Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy.
Am J Hematol
; 89(9): 933-4, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861480
12.
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
Eur J Haematol
; 81(3): 165-9, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18510702
13.
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.
Oncotarget
; 9(18): 14219-14227, 2018 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29581839
14.
How could patient reported outcomes improve patient management in chronic myeloid leukemia?
Expert Rev Hematol
; 10(1): 9-14, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27858461
15.
Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.
J Clin Oncol
; 32(31): 3497-505, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25267759
16.
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy.
Am J Hematol
; 83(6): 517-8, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18306359
17.
Long lasting remission after haploidentical stem cell transplant and pre-emptive donor lymphocyte infusions in a patient with primary refractory Hodgkin lymphoma.
Leuk Lymphoma
; 56(4): 1129-31, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25058370
18.
Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complications after allogeneic stem cell transplantation.
Curr Stem Cell Res Ther
; 4(2): 161-7, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19442201
19.
Cardiotoxicity of imatinib: At the heart of the problem.
Leuk Res
; 35(1): 36-7, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20970188